Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC lifted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 26.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,500 shares of the biotechnology company’s stock after purchasing an additional 742 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Axon Enterprise were worth $904,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. HB Wealth Management LLC increased its stake in shares of Axon Enterprise by 3.9% in the 4th quarter. HB Wealth Management LLC now owns 1,139 shares of the biotechnology company’s stock worth $294,000 after acquiring an additional 43 shares during the last quarter. UMB Bank n.a. increased its position in Axon Enterprise by 11.0% during the fourth quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock worth $115,000 after purchasing an additional 44 shares during the last quarter. CWM LLC raised its stake in Axon Enterprise by 1.8% during the third quarter. CWM LLC now owns 2,669 shares of the biotechnology company’s stock worth $531,000 after purchasing an additional 46 shares during the period. Greenleaf Trust boosted its holdings in Axon Enterprise by 3.6% in the 3rd quarter. Greenleaf Trust now owns 1,540 shares of the biotechnology company’s stock valued at $306,000 after purchasing an additional 54 shares during the last quarter. Finally, Czech National Bank grew its stake in shares of Axon Enterprise by 0.4% in the 4th quarter. Czech National Bank now owns 12,336 shares of the biotechnology company’s stock valued at $3,187,000 after buying an additional 54 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Down 2.4 %

Shares of NASDAQ:AXON opened at $303.31 on Tuesday. The firm has a market capitalization of $22.89 billion, a PE ratio of 131.87 and a beta of 0.93. Axon Enterprise, Inc. has a 1 year low of $175.37 and a 1 year high of $329.87. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66. The firm’s 50-day moving average is $298.34 and its two-hundred day moving average is $256.00.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.29. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The firm had revenue of $432.14 million during the quarter, compared to analysts’ expectations of $418.97 million. Analysts predict that Axon Enterprise, Inc. will post 2.43 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on AXON shares. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. JMP Securities upped their price target on Axon Enterprise from $250.00 to $285.00 and gave the company a “market outperform” rating in a research note on Tuesday, February 6th. JPMorgan Chase & Co. raised their price objective on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research report on Thursday, April 11th. Needham & Company LLC upped their target price on shares of Axon Enterprise from $315.00 to $400.00 and gave the company a “buy” rating in a research report on Wednesday, April 10th. Finally, Robert W. Baird increased their target price on shares of Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, February 22nd. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $312.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.